{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and\/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release","item":"https:\/\/www.regionalcancercare.org\/trials\/managed-access-program-map-to-provide-access-to-ctl019-for-all-or-dlbcl-patients-with-out-of-specification-leukapheresis-product-and-or-manufactured-tisagenlecleucel-out-of-specification-for-commer\/#breadcrumbitem"}]}